Imitrex Related Published Studies
Well-designed clinical trials related to Imitrex (Sumatriptan)
Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. [2008.07.08]
Activation of the cortical pain network by soft tactile stimulation after injection of sumatriptan. [2007.12.15]
Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. [2007.09]
Sumatriptan for prevention of acute mountain sickness: Randomized clinical trial. [2007.06.07]
Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes. [2007.06.07]
Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. [2007.04.04]
Intranasal sumatriptan study with high placebo response in Taiwanese patients with migraine. [2007.02]
Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform. [2006.07]
A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines. [2006.06]
A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. [2006.04]
Subcutaneous sumatriptan for refractory trigeminal neuralgia. [2006.04]
Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients. [2006.03.14]
Pain free efficacy of sumatriptan in the early treatment of migraine. [2006.02]
Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. [2006.02]
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. [2006.01]
Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries. [2005.11]
Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. [2005.10]
Sumatriptan and naproxen sodium for the acute treatment of migraine. [2005.09]
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. [2005.09]
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. [2005.07]
Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study. [2005.05]
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. [2005.04]
Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan. [2005.04]
Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan. [2005.04]
A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. [2005.02.08]
Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan. [2005.02]
In vivo disintegration profiles of encapsulated and nonencapsulated sumatriptan: gamma scintigraphy in healthy volunteers. [2005.01]
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. [2005]
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine. [2004.12]
Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia. [2004.12]
Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. [2004.11]
Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. [2004.11]
Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. [2004.10]
Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets. [2004.07]
Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers. [2004.06]
Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial. [2004.03.23]
Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. [2004.02]
Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan. [2004]
Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. [2004]
Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. [2003.10]
Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. [2003.10]
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet. [2003.09]
Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. [2003.09]
Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. [2003.07]
A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine. [2003.07]
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. [2003.07]
A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. [2003.05]
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg. [2003.03]
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. [2003.02.25]
Effect of the 5-HT1 agonist sumatriptan on oesophageal motor pattern in patients with ineffective oesophageal motility. [2003.02]
Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. [2003.02]
Oral sumatriptan for acute migraine. [2003]
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. [2002.10.22]
A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration. [2002.05]
CNS effects of sumatriptan and rizatriptan in healthy female volunteers. [2002.05]
The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers. [2002.04]
Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms. [2002.02]
Transient minor improvement of high altitude headache by sumatriptan. [2002.01]
Intraoral chilling versus oral sumatriptan for acute migraine. [2001.11]
Efficacy and tolerability of subcutaneous sumatriptan for acute migraine: a comparison between ethnic groups. [2001.10]
Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. [2001.09]
Effect of intranasal sumatriptan on gastric tone and sensitivity to distension. [2001.08]
The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. [2001.07]
Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison. [2001.06]
Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. [2001.05]
Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. [2001.04]
Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. [2001.04]
Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets. [2001.02]
Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine. [2001.02]
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan. [2001.01]
Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine. [2001]
2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. [2000.11]
A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. [2000.11]
Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks. [2000.10]
Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. [2000.08]
Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. [2000.08]
Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. [2000.07]
A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. [2000.06]
Naproxen sodium decreases migraine recurrence when administered with sumatriptan. [2000.06]
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism? [2000.06]
Increased growth hormone response to sumatriptan challenge in adult autistic disorders. [2000.05.15]
Sumatriptan in patients with postdural puncture headache. [2000.04]
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. [2000.02]
A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. [2000.02]
The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. [2000.02]
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. [2000.01.11]
Lack of pharmacokinetic interaction between sumatriptan and naproxen. [2000.01]
The effectiveness of combined oral lysine acetylsalicylate and metoclopramide (Migpriv) in the treatment of migraine attacks. Comparison with placebo and oral sumatriptan. [2000]
Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study. [2000]
A dose-defining study of sumatriptan suppositories in the acute treatment of migraine. [1999.12]
Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group. [1999.08]
A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. [1999.08]
Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor. [1999.08]
Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. [1999.07]
Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan. [1999.07]
Intranasal sumatriptan for the acute treatment of migraine in children. [1999.04.22]
A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension. [1999.03]
Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine. [1999.01]
Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group. [1999]
Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation. [1998.12]
Exercise testing in patients with chest pain to sumatriptan. [1998.12]
|
